Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-105,006
Closed -$3.28M 141
2022
Q4
$3.28M Sell
105,006
-34,900
-25% -$1.28M 0.93% 42
2022
Q3
$5.88M Sell
139,906
-5,500
-4% -$222K 1.68% 11
2022
Q2
$5.93M Sell
145,406
-30,000
-17% -$1.11M 1.64% 15
2022
Q1
$6.37M Sell
175,406
-5,046
-3% -$167K 1.2% 28
2021
Q4
$6.1M Sell
180,452
-15,413
-8% -$532K 1.08% 30
2021
Q3
$7.04M Hold
195,865
1.01% 27
2021
Q2
$6.29M Buy
195,865
+25,000
+15% +$745K 0.87% 34
2021
Q1
$5.14M Sell
170,865
-9,135
-5% -$237K 0.74% 43
2020
Q4
$3.82M Buy
+180,000
New +$4.47M 0.64% 39
2017
Q4
Sell
-292,888
Closed -$5.22M 143
2017
Q3
$5.22M Sell
292,888
-143,312
-33% -$2.54M 0.82% 41
2017
Q2
$7.82M Sell
436,200
-126,120
-22% -$2.42M 1.34% 22
2017
Q1
$10.8M Sell
562,320
-23,085
-4% -$418K 2.25% 8
2016
Q4
$10M Buy
585,405
+265,205
+83% +$3.83M 2.34% 8
2016
Q3
$4.59M Buy
+320,200
New +$4.09M 1.04% 31

Other funds holding LRN

Formula Growth's LRN Position: Q1 2023 in Review

Formula Growth sold out of Stride (LRN) in Q1 2023, closing a stake of 105,006 shares — an estimated $3.28M sold.

Formula Growth first reported a position in LRN in Q3 2016 and held it in 14 quarters. The position peaked at $10.8M in Q1 2017. 235 funds tracked by Wall St. Rank hold LRN as of Q1 2023.

  • Formula Growth reported no remaining Stride position as of Q1 2023 after selling out during the quarter.
  • Formula Growth sold 105,006 Stride shares in Q1 2023, an estimated $3.28M.
  • Formula Growth first reported a position in Stride in Q3 2016 and held it in 14 quarters.
  • Formula Growth's Stride position peaked at $10.8M in Q1 2017.
  • 235 funds tracked by Wall St. Rank held Stride as of Q1 2023.

Based on Formula Growth's 13F filing for Q1 2023, filed 12 May 2023.